XML 53 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders’ Equity (Tables)
12 Months Ended
Jan. 03, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Allocated Employee Stock-Based Compensation Expense
We allocated the stock-based compensation expense for our equity incentive plans and our ESPP as follows (in thousands):
 
Year Ended December 31,
 
202420232022
Research and development$30,670 $34,320 $45,350 
Selling, general and administrative63,166 72,025 62,224 
Total stock-based compensation expense$93,836 $106,345 $107,574 
 
Year Ended December 31,
 
202420232022
Stock options$6,035 $7,771 $12,790 
Restricted stock units81,130 70,462 69,775 
Performance stock units3,058 23,938 21,616 
Employee stock purchase plan3,613 4,174 3,393 
Total stock-based compensation expense$93,836 $106,345 $107,574 
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value per share of stock options and ESPP purchases were as follows:
 
Year Ended December 31,
 
202420232022
Stock options$9.79 $9.45 $8.36 
ESPP$6.39 $4.67 $5.80 
Schedule of Fair Value of Employee Share-Based Payments Awards Stock Option Assumptions and Weighted Average Fair Values
The grant-date fair value of stock option grants and ESPP purchases was estimated using the following weighted average assumptions:
 
Year Ended December 31,
 
202420232022
Stock options:
Risk-free interest rate4.40 %4.14 %2.35 %
Dividend yield— %— %— %
Volatility39 %44 %48 %
Expected life5.6 years5.6 years4.6 years
ESPP:
Risk-free interest rate5.15 %5.07 %1.49 %
Dividend yield— %— %— %
Volatility34 %40 %45 %
Expected life6 months6 months6 months
Schedule of Fair Value of Employee Share-Based Payments Awards ESPP Assumptions and Weighted Average Fair Values
The grant-date fair value of stock option grants and ESPP purchases was estimated using the following weighted average assumptions:
 
Year Ended December 31,
 
202420232022
Stock options:
Risk-free interest rate4.40 %4.14 %2.35 %
Dividend yield— %— %— %
Volatility39 %44 %48 %
Expected life5.6 years5.6 years4.6 years
ESPP:
Risk-free interest rate5.15 %5.07 %1.49 %
Dividend yield— %— %— %
Volatility34 %40 %45 %
Expected life6 months6 months6 months
Schedule of All Stock Option Activity
Activity for stock options during the year ended December 31, 2024 was as follows (in thousands, except per share amounts):
Shares
Weighted  Average Exercise Price
Weighted  Average Remaining Contractual Term
Aggregate Intrinsic Value
Stock options outstanding at December 31, 2023
8,208 $21.24 2.7 years$24,115 
Granted124 $22.46 
Exercised(3,051)$21.78 
Cancelled(665)$23.22 
Stock options outstanding at December 31, 2024
4,616 $20.64 2.5 years$61,551 
Stock options exercisable at December 31, 2024
4,106 $20.58 2.2 years$54,974 
Schedule of All RSU Activity Activity for RSUs during the year ended December 31, 2024 was as follows (in thousands, except per share amounts):
Shares
Weighted  Average Grant Date Fair Value
Weighted  Average Remaining Contractual  Term
Aggregate Intrinsic Value
RSUs outstanding at December 31, 2023
11,874 $22.72 1.7 years$284,856 
Awarded5,974 $21.74 
Vested and released(2,845)$20.71 
Forfeited(2,063)$21.86 
RSUs outstanding at December 31, 2024
12,940 $22.84 1.5 years$439,580 
Activity for PSUs during the year ended December 31, 2024 was as follows (in thousands, except per share amounts):
Shares
Weighted  Average Grant Date Fair Value
Weighted  Average Remaining Contractual  Term
Aggregate Intrinsic Value
PSUs outstanding at December 31, 2023
3,891 $23.60 1.3 years$93,351 
Awarded192 $24.54 
Vested and released(901)$23.87 
Forfeited(2,733)$23.42 
PSUs outstanding at December 31, 2024
449 $24.54 0.1 years$15,257 
Schedule of Share-Based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions
We used a Monte Carlo simulation model and the following weighted-average assumptions to determine the weighted-average grant date fair value of $20.19 per share for the 2024 TSR-based RSUs, $26.05 per share for the 2023 TSR-based RSUs, $33.17 per share for the 2022 TSR-based RSUs, and $24.54 per share for the 2021 PSUs:
2024 TSR-Based RSUs2023 TSR-Based RSUs2022 TSR-Based RSUs2021 PSUs
Fair value of Exelixis common stock on grant date$21.71 $19.48 $20.70 $21.31 
Expected volatility36.68 %40.26 %46.85 %49.21 %
Risk-free interest rate4.42 %3.75 %1.59 %0.29 %
Dividend yield— %— %— %— %